Mealey's (September 5, 2017, 2:20 PM EDT) -- WASHINGTON, D.C. — A federal district court did not err in denying a company’s motion for a new trial following a jury’s award of a $70 million verdict on claims for misappropriation of trade secrets and a federal judge’s order requiring the company to pay an additional $21 million because a damages award in the action was not “against the clear weight of the evidence,” a Federal Circuit U.S. Court of Appeals panel ruled Sept. 1 in affirming the lower court’s ruling (CardiAQ Valve Technologies, Inc. v. Neovasc Inc., Nos. 17-1302, 17-1513, Fed. Cir., 2017 U.S. App. LEXIS 16856)....